S
Salvatore Gueli Alletti
Researcher at Catholic University of the Sacred Heart
Publications - 77
Citations - 2050
Salvatore Gueli Alletti is an academic researcher from Catholic University of the Sacred Heart. The author has contributed to research in topics: Medicine & Hysterectomy. The author has an hindex of 22, co-authored 63 publications receiving 1422 citations. Previous affiliations of Salvatore Gueli Alletti include Agostino Gemelli University Polyclinic & The Catholic University of America.
Papers
More filters
Journal ArticleDOI
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome.
Anna Fagotti,Gabriella Ferrandina,Giuseppe Vizzielli,Francesco Fanfani,Valerio Gallotta,Vito Chiantera,Barbara Costantini,P.A. Margariti,Salvatore Gueli Alletti,Francesco Cosentino,Lucia Tortorella,Giovanni Scambia +11 more
TL;DR: Perioperative moderate/severe morbidity as well as QoL scores were shown to be more favourable in NACT/IDS arm than PDS in AEOC patients with very HTL, and emotional functioning, cognitive functioning, nausea/vomiting, dyspnoea, insomnia and hair loss were statistically and clinically better in Nact/IDS compared to PDS arm.
Journal ArticleDOI
Postoperative pain after conventional laparoscopy and laparoendoscopic single site surgery (LESS) for benign adnexal disease: a randomized trial.
Anna Fagotti,Carolina Bottoni,Giuseppe Vizzielli,Salvatore Gueli Alletti,Giovanni Scambia,Elisabetta Marana,Francesco Fanfani +6 more
TL;DR: LESS provides an advantage over conventional multiaccess LPS in terms of postoperative pain and need for rescue analgesia, with similar perioperative outcomes.
Journal ArticleDOI
Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850).
Anna Fagotti,Maria Gabriella Ferrandina,Giuseppe Vizzielli,Tina Pasciuto,Francesco Fanfani,Valerio Gallotta,P.A. Margariti,Vito Chiantera,Barbara Costantini,Salvatore Gueli Alletti,Francesco Cosentino,Giovanni Scambia +11 more
TL;DR: Neoadjuvant chemotherapy and primary debulking surgery have the same efficacy when used at their maximal possibilities, but the toxicity profile is different.
Journal ArticleDOI
Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): A feasibility study
Salvatore Gueli Alletti,Carolina Bottoni,Francesco Fanfani,Valerio Gallotta,Vito Chiantera,Barbara Costantini,Francesco Cosentino,Alfredo Ercoli,Giovanni Scambia,Anna Fagotti +9 more
TL;DR: Invasive-IDS in patients with clinically complete response to NACT seems to be feasible and safe in terms of perioperative outcomes, psycho-oncological impact, and survival rate.
Journal ArticleDOI
The new robotic TELELAP ALF-X in gynecological surgery: single-center experience
Francesco Fanfani,Giorgia Monterossi,Anna Fagotti,Cristiano Rossitto,Salvatore Gueli Alletti,Barbara Costantini,Valerio Gallotta,Luigi Selvaggi,Stefano Restaino,Giovanni Scambia +9 more
TL;DR: The first series of a novel robotic approach for the treatment of various gynecological conditions is reported, showing that when performed by experienced minimally invasive surgeons, TELELAP ALF-X is feasible and safe.